The pivotal Phase 3 clinical trial NefIgArd Part A fully recruited December 23, 2019 08:00 CET Non Regulatory Read more
Calliditas Therapeutics Capital Markets Day today November 4 November 4, 2019 08:00 CET Non Regulatory Read more
Save the date: Calliditas to host Capital Markets Day in Stockholm on November 4, 2019 October 1, 2019 13:00 CET Non Regulatory Read more
Calliditas Therapeutics to host conference call to provide Business Update and 2019 Q2 report August 12, 2019 12:00 CET Non Regulatory Read more
Calliditas Therapeutics to Present at Redeye Growth Day June 4, 2019 13:00 CET Non Regulatory Read more
Calliditas Therapeutics to host conference call to provide Business Update and 2019 Q1 report May 6, 2019 15:00 CET Non Regulatory Read more
Elmar Schnee and Diane Parks proposed as new board members of Calliditas Therapeutics April 5, 2019 11:15 CET Non Regulatory Read more
Calliditas Therapeutics to Present at the Needham Healthcare Conference April 3, 2019 13:00 CET Non Regulatory Read more
Calliditas Therapeutics to Present at March Investor Conferences March 4, 2019 10:00 CET Non Regulatory Read more
Calliditas Therapeutics to host conference call to provide Business Update and 2018 full-year report February 1, 2019 10:00 CET Non Regulatory Read more
Calliditas Therapeutics appoints Frank Bringstrup as VP Regulatory Affairs January 14, 2019 14:30 CET Non Regulatory Read more
Calliditas Therapeutics appoints Andrew Udell to VP Commercial, North America January 8, 2019 07:00 CET Non Regulatory Read more